{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T01:40:50Z","timestamp":1780537250554,"version":"3.54.1"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T00:00:00Z","timestamp":1724371200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T00:00:00Z","timestamp":1724371200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"European Union - EDCTP2","award":["TMA2017GSF-1962-CaDERAL"],"award-info":[{"award-number":["TMA2017GSF-1962-CaDERAL"]}]},{"name":"European Union - EDCTP2","award":["TMA2017GSF-1962-CaDERAL"],"award-info":[{"award-number":["TMA2017GSF-1962-CaDERAL"]}]},{"name":"European Union - EDCTP2","award":["TMA2017GSF-1962-CaDERAL"],"award-info":[{"award-number":["TMA2017GSF-1962-CaDERAL"]}]},{"name":"European Union - EDCTP2","award":["TMA2017GSF-1962-CaDERAL"],"award-info":[{"award-number":["TMA2017GSF-1962-CaDERAL"]}]},{"name":"European Union - EDCTP2","award":["TMA2017GSF-1962-CaDERAL"],"award-info":[{"award-number":["TMA2017GSF-1962-CaDERAL"]}]},{"name":"European Union - EDCTP2","award":["TMA2017GSF-1962-CaDERAL"],"award-info":[{"award-number":["TMA2017GSF-1962-CaDERAL"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-024-03711-x","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T20:10:16Z","timestamp":1724443816000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prevalence and associations of chronic kidney disease among antiretroviral therapy-na\u00efve persons living with HIV in Lagos, Nigeria"],"prefix":"10.1186","volume":"25","author":[{"given":"Oluwatosin Olaseni","family":"Odubela","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nkiruka Nnonyelum","family":"Odunukwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasheeta","family":"Peer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adesola Zaidat","family":"Musa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babatunde Lawal","family":"Salako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre Pascal","family":"Kengne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,23]]},"reference":[{"key":"3711_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1744-8603-7-1","volume":"7","author":"CJ Colvin","year":"2011","unstructured":"Colvin CJ. HIV \/ AIDS, chronic diseases and globalisation. Global Health. 2011;7:1\u20136.","journal-title":"Global Health."},{"key":"3711_CR2","first-page":"211","volume":"11","author":"R Baryamutuma","year":"2011","unstructured":"Baryamutuma R, Baingana F. Sexual, reproductive health needs and rights of young people with perinatally acquired HIV in Uganda. Afr Health Sci. 2011;11:211\u20138.","journal-title":"Afr Health Sci."},{"key":"3711_CR3","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.1681\/ASN.2017040468","volume":"28","author":"V Jotwani","year":"2017","unstructured":"Jotwani V, Atta MG, Estrella MM. Kidney disease in HIV: Moving beyond HIV-associated nephropathy. Journal of the American Society of Nephrology. 2017;28:3142\u201354.","journal-title":"Journal of the American Society of Nephrology."},{"key":"3711_CR4","unstructured":"UNAIDS, UN Interagency Task force on NCDs. Responding to the Challenge of NonCommunicable diseases. 2019."},{"key":"3711_CR5","first-page":"1","volume":"40","author":"A Bertoldi","year":"2017","unstructured":"Bertoldi A, De Crignis E, Miserocchi A, Bon I, Musumeci G, Longo S, et al. HIV and kidney: A dangerous liaison. New Microbiologica. 2017;40:1\u201310.","journal-title":"New Microbiologica."},{"key":"3711_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0195443","volume":"13","author":"UE Ekrikpo","year":"2018","unstructured":"Ekrikpo UE, Kengne AP, Bello AK, Effa EE, Noubiap JJ, Salako BL, et al. Chronic kidney disease in the global adult HIV-infected population: A systematic review and meta-analysis. PLoS One. 2018;13: e0195443.","journal-title":"PLoS One."},{"key":"3711_CR7","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/nrneph.2016.163","volume":"13","author":"RJ Glassock","year":"2017","unstructured":"Glassock RJ, Warnock DG, Delanaye P. The global burden of chronic kidney disease: Estimates, variability and pitfalls. Nat Rev Nephrol. 2017;13:104\u201314.","journal-title":"Nat Rev Nephrol."},{"key":"3711_CR8","doi-asserted-by":"crossref","unstructured":"Zhang QL, Rothenbacher D. Prevalence of chronic kidney disease in population-based studies: Systematic review. BMC Public Health. 2008;8.","DOI":"10.1186\/1471-2458-8-117"},{"key":"3711_CR9","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.kint.2019.07.012","volume":"96","author":"KJ Jager","year":"2019","unstructured":"Jager KJ, Kovesdy C, Langham R, Rosenberg M, Jha V, Zoccali C. A single number for advocacy and communication\u2014worldwide more than 850 million individuals have kidney diseases. Kidney Int. 2019;96:1048\u201350.","journal-title":"Kidney Int."},{"key":"3711_CR10","doi-asserted-by":"crossref","unstructured":"Heron JE, Bagnis CI, Gracey DM. Contemporary issues and new challenges in chronic kidney disease amongst people living with HIV. AIDS Res Ther. 2020;17.","DOI":"10.1186\/s12981-020-00266-3"},{"key":"3711_CR11","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1111\/nep.13714","volume":"25","author":"Z Sui","year":"2020","unstructured":"Sui Z, Wang J, Cabrera C, Wei J, Wang M, Zuo L. Aetiology of chronic kidney disease and risk factors for disease progression in Chinese subjects: A single-centre retrospective study in Beijing. Nephrology. 2020;25:714\u201322.","journal-title":"Nephrology."},{"key":"3711_CR12","doi-asserted-by":"crossref","unstructured":"Swanepoel CR, Atta MG, D\u2019Agati VD, Estrella MM, Fogo AB, Naicker S, et al. Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. In: Kidney International. Elsevier B.V.; 2018. p. 545\u201359.","DOI":"10.24884\/1561-6274-2018-22-6-84-100"},{"key":"3711_CR13","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/nrneph.2015.9","volume":"11","author":"AZ Rosenberg","year":"2015","unstructured":"Rosenberg AZ, Naicker S, Winkler CA, Kopp JB. HIV-associated nephropathies: Epidemiology, pathology, mechanisms and treatment. Nat Rev Nephrol. 2015;11:150\u201360.","journal-title":"Nat Rev Nephrol."},{"key":"3711_CR14","unstructured":"WHO. Epidemiological fact sheet: HIV statistics, globally and by WHO region, 2023. 2023."},{"key":"3711_CR15","unstructured":"UNAIDS. UNAIDS data 2022. 2023."},{"key":"3711_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-015-1157-8","volume":"15","author":"TM Temu","year":"2015","unstructured":"Temu TM, Kirui N, Wanjalla C, Ndungu AM, Kamano JH, Inui TS, et al. Cardiovascular health knowledge and preventive practices in people living with HIV in Kenya. BMC Infect Dis. 2015;15:1\u20138.","journal-title":"BMC Infect Dis."},{"key":"3711_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12977-019-0497-7","volume":"16","author":"AG Vos","year":"2019","unstructured":"Vos AG, Hoeve K, Barth RE, Peper J, Moorhouse M, Crowther NJ, et al. Cardiovascular disease risk in an urban African population: A cross-sectional analysis on the role of HIV and antiretroviral treatment. Retrovirology. 2019;16:1\u201310.","journal-title":"Retrovirology."},{"key":"3711_CR18","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1093\/ndt\/gfm836","volume":"23","author":"CP Emem","year":"2008","unstructured":"Emem CP, Arogundade F, Sanusi A, Adelusola K, Wokoma F, Akinsola A. Renal disease in HIV-seropositive patients in Nigeria: An assessment of prevalence, clinical features and risk factors. Nephrology Dialysis Transplantation. 2008;23:741\u20136.","journal-title":"Nephrology Dialysis Transplantation."},{"key":"3711_CR19","doi-asserted-by":"crossref","unstructured":"Ekrikpo UE, Akpan EE, Ekott JU, Bello AK, Okpechi IG, Kengne AP. Prevalence and correlates of traditional risk factors for cardiovascular disease in a Nigerian ART-naive HIV population: A cross-sectional study. BMJ Open. 2018;8.","DOI":"10.1136\/bmjopen-2017-019664"},{"key":"3711_CR20","doi-asserted-by":"publisher","first-page":"60","DOI":"10.38029\/bumj.v4i1.76","volume":"4","author":"O Egbi","year":"2021","unstructured":"Egbi O. Prevalence of Kidney impairment and its associated factors among HIV-infected antiretroviral treatment-na\u00efve adult patients in Bayelsa State, Nigeria. Babcock University Medical Journal (BUMJ). 2021;4:60\u201370.","journal-title":"Babcock University Medical Journal (BUMJ)."},{"key":"3711_CR21","doi-asserted-by":"crossref","unstructured":"Okafor UH, Unuigbe EI, Ojogwu LI, Oviasu E, Wokoma FS. Renal disease in HIV infected patients at university of Benin teaching hospital in Nigeria. Afr Health Sci. 2011;11(Suppl 1): S28\u2013S33.","DOI":"10.4314\/ahs.v11i3.70067"},{"key":"3711_CR22","first-page":"177","volume":"37","author":"DS Ayokunle","year":"2015","unstructured":"Ayokunle DS, Olusegun OT, Ademola A, Adindu C, Olaitan RM, Oladimeji AA. Prevalence of chronic kidney disease in newly diagnosed patients with Human immunodeficiency virus in Ilorin. Nigeria J Bras Nefrol. 2015;37:177\u201384.","journal-title":"Nigeria. J Bras Nefrol."},{"key":"3711_CR23","doi-asserted-by":"publisher","first-page":"42","DOI":"10.4103\/smj.smj_53_16","volume":"21","author":"EE Abene","year":"2018","unstructured":"Abene EE, Gimba ZM, Agbaji OO, Agaba EI. Prevalence of chronic kidney disease among antiretroviral na\u00efve human immunodeficiency virus-infected patients. Sahel Medical Journal. 2018;21:42\u20136.","journal-title":"Sahel Medical Journal."},{"key":"3711_CR24","doi-asserted-by":"publisher","first-page":"182","DOI":"10.4103\/0300-1652.86133","volume":"52","author":"O Agbaji","year":"2011","unstructured":"Agbaji O, Agaba P, Falang K, Onu A, Muazu M, Idoko J. Predictors of impaired renal function among HIV infected patients commencing highly active antiretroviral therapy in Jos. Nigeria Nigerian Medical Journal. 2011;52:182.","journal-title":"Nigeria. Nigerian Medical Journal."},{"key":"3711_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12882-019-1335-9","volume":"20","author":"NF Kabor\u00e9","year":"2019","unstructured":"Kabor\u00e9 NF, Poda A, Zoungrana J, Da O, Ciaffi L, Semd\u00e9 A, et al. Chronic kidney disease and HIV in the era of antiretroviral treatment: Findings from a 10-year cohort study in a west African setting. BMC Nephrol. 2019;20:1\u201310.","journal-title":"BMC Nephrol."},{"key":"3711_CR26","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/hiv.13019","volume":"22","author":"R Hsu","year":"2021","unstructured":"Hsu R, Brunet L, Fusco J, Beyer A, Prajapati G, Wyatt C, et al. Risk of chronic kidney disease in people living with HIV by tenofovir disoproxil fumarate (TDF) use and baseline D:A: D chronic kidney disease risk score. HIV Med. 2021;22:325\u201333.","journal-title":"HIV Med."},{"key":"3711_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.106154","volume":"56","author":"A Vergori","year":"2020","unstructured":"Vergori A, Gagliardini R, Gianotti N, Gori A, Lichtner M, Saracino A, et al. Switching from tenofovir disoproxil fumarate to tenofovir alafenamide or dual therapy-based regimens in HIV-infected individuals with viral load \u226450 copies\/mL: does estimated glomerular filtration rate matter? Int J Antimicrob Agents. 2020;56: 106154.","journal-title":"Int J Antimicrob Agents."},{"key":"3711_CR28","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","volume":"75","author":"T Unger","year":"2020","unstructured":"Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension. 2020;75:1334\u201357.","journal-title":"Hypertension."},{"key":"3711_CR29","unstructured":"Federal Ministry of Health Nigeria. The National Strategic Plan for Tuberculosis and Leprosy Control (2010-2015). 2011."},{"key":"3711_CR30","unstructured":"Federal Ministry of Health (FMoH) Nigeria, National Tuberculosis L& BUCP, National AIDS & STIs Control Programme. National Guidelines for the Management of TB\/HIV Co-infection in Nigeria. Abuja; 2021."},{"key":"3711_CR31","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1373\/clinchem.2012.184259","volume":"59","author":"EJ Lamb","year":"2013","unstructured":"Lamb EJ, Levey AS, Stevens PE. The kidney disease improving global outcomes (KDIGO) guideline update for chronic kidney disease: Evolution not revolution. Clin Chem. 2013;59:462\u20135.","journal-title":"Clin Chem."},{"key":"3711_CR32","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl (2011). 2013;3:1\u2013150."},{"key":"3711_CR33","first-page":"263","volume":"21","author":"D Du Bois","year":"1916","unstructured":"Du Bois D, Du Bois E. A formula to estimate the approximate surface area if Height and weight be known. The Archives of Internal Medicine. 1916;21:263\u20138.","journal-title":"The Archives of Internal Medicine."},{"key":"3711_CR34","first-page":"576","volume":"20","author":"G Rostoker","year":"2007","unstructured":"Rostoker G, Andrivet P, Pham I, Griuncelli M, Adnot S. A modified Cockcroft-Gault formula taking into account the body surface area gives a more accurate estimation of the glomerular filtration rate. J Nephrol. 2007;20:576\u201385.","journal-title":"J Nephrol."},{"key":"3711_CR35","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000180580","volume":"16","author":"DW Cockcroft","year":"1976","unstructured":"Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31\u201341.","journal-title":"Nephron."},{"key":"3711_CR36","doi-asserted-by":"publisher","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","volume":"130","author":"AS Levey","year":"1999","unstructured":"Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation. Ann Intern Med. 1999;130:461\u201370.","journal-title":"Ann Intern Med."},{"key":"3711_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/2141038","volume":"2020","author":"AD Rocha","year":"2020","unstructured":"Rocha AD, Garcia S, Santos AB, Eduardo JCC, Mesquita CT, Lugon JR, et al. No Race-Ethnicity Adjustment in CKD-EPI Equations Is Required for Estimating Glomerular Filtration Rate in the Brazilian Population. Int J Nephrol. 2020;2020:1\u20139.","journal-title":"Int J Nephrol."},{"key":"3711_CR38","doi-asserted-by":"crossref","unstructured":"Levey AS, Stevens LA, Christopher H. Schmid, Yaping (Lucy) Zhang AFCI, Feldman HI, Kusek JW, Eggers P, et al. A New Equation to Estimate Glomerular Filtration Rate. Ann Intern Med. 2009;150:604\u201312.","DOI":"10.7326\/0003-4819-150-9-200905050-00006"},{"key":"3711_CR39","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1373\/clinchem.2006.077180","volume":"53","author":"AS Levey","year":"2007","unstructured":"Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek JW, et al. Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem. 2007;53:766\u201372.","journal-title":"Clin Chem."},{"key":"3711_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2369-14-75","volume":"14","author":"TE Matsha","year":"2013","unstructured":"Matsha TE, Yako YY, Rensburg MA, Hassan MS, Kengne AP, Erasmus RT. Chronic kidney diseases in mixed ancestry south African populations: Prevalence, determinants and concordance between kidney function estimators. BMC Nephrol. 2013;14:1\u201310.","journal-title":"BMC Nephrol."},{"key":"3711_CR41","unstructured":"WHO. Obesity: Preventing and Managing the Global Epidemic. 2000."},{"key":"3711_CR42","unstructured":"UNAIDS. People living with HIV who have suppressed viral loads. 2020. https:\/\/indicatorregistry.unaids.org\/indicator\/people-living-hiv-who-have-suppressed-viral-loads. Accessed 10 Oct 2022."},{"key":"3711_CR43","unstructured":"CDC. Terms, Definitions, and Calculations Used in CDC HIV Surveillance Publications. Centers for Disease Control and Prevention. 2016; December:1\u20133."},{"key":"3711_CR44","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/j.1365-2249.2005.02857.x","volume":"141","author":"M Vajpayee","year":"2005","unstructured":"Vajpayee M, Kaushik S, Sreenivas V, Wig N, Seth P. CDC staging based on absolute CD 4 count and CD 4 percentage in an HIV- 1 -infected Indian population: treatment implications. Clin Exp Immunol. 2005;141:485\u201390.","journal-title":"Clin Exp Immunol."},{"key":"3711_CR45","unstructured":"Federal Ministry of Health. Nigeria HIV\/AIDS Indicator and Impact Survey (NAIIS) 2018: Technical Report. Abuja; 2019."},{"key":"3711_CR46","doi-asserted-by":"publisher","first-page":"276","DOI":"10.11613\/BM.2012.031","volume":"22","author":"ML McHugh","year":"2012","unstructured":"McHugh ML. Interrater reliability: the kappa statistic. Biochem Med (Zagreb). 2012;22:276.","journal-title":"Biochem Med (Zagreb)."},{"key":"3711_CR47","doi-asserted-by":"publisher","first-page":"591","DOI":"10.2147\/HIV.S276356","volume":"12","author":"GA Manaye","year":"2020","unstructured":"Manaye GA, Abateneh DD, Niguse W. Chronic Kidney Disease and Associated Factors Among HIV\/AIDS Patients on HAART in Ethiopia. HIV\/AIDS - Research and Palliative Care. 2020;12:591\u20139.","journal-title":"HIV\/AIDS - Research and Palliative Care."},{"key":"3711_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12882-020-02126-8","volume":"21","author":"TO Olanrewaju","year":"2020","unstructured":"Olanrewaju TO, Aderibigbe A, Popoola AA, Braimoh KT, Buhari MO, Adedoyin OT, et al. Prevalence of chronic kidney disease and risk factors in North-Central Nigeria: a population-based survey. BMC Nephrol. 2020;21:1\u201310.","journal-title":"BMC Nephrol."},{"key":"3711_CR49","unstructured":"National AIDS and STIs Control Programme, Federal Ministry of Health Nigeria. National Guidelines for HIV Prevention, Treatment and Care. Abuja; 2020."},{"key":"3711_CR50","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1093\/ckj\/sfac151","volume":"15","author":"A Ortiz","year":"2022","unstructured":"Ortiz A, Mattace-Raso F, Soler MJ, Fouque D. Ageing meets kidney disease. Clin Kidney J. 2022;15:1793\u20136.","journal-title":"Clin Kidney J."},{"key":"3711_CR51","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1681\/ASN.2017040421","volume":"28","author":"MS Hommos","year":"2017","unstructured":"Hommos MS, Glassock RJ, Rule AD. Structural and functional changes in human kidneys with healthy aging. Journal of the American Society of Nephrology. 2017;28:2838\u201344.","journal-title":"Journal of the American Society of Nephrology."},{"key":"3711_CR52","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1159\/000445450","volume":"134","author":"RJ Glassock","year":"2016","unstructured":"Glassock RJ, Rule AD. Aging and the Kidneys: Anatomy, Physiology and Consequences for Defining Chronic Kidney Disease. Nephron. 2016;134:25\u20139.","journal-title":"Nephron."},{"key":"3711_CR53","doi-asserted-by":"crossref","unstructured":"Zicari S, Sessa L, Cotugno N, Ruggiero A, Morrocchi E, Concato C, et al. Immune activation, inflammation, and non-AIDS co-morbidities in HIV-infected patients under long-term ART. Viruses. 2019;11(3):200.","DOI":"10.3390\/v11030200"},{"key":"3711_CR54","doi-asserted-by":"crossref","unstructured":"Thurman M, Johnson S, Acharya A, Pallikkuth S, Mahesh M, Byrareddy SN. Biomarkers of Activation and Inflammation to Track Disparity in Chronological and Physiological Age of People Living With HIV on Combination Antiretroviral Therapy. Front Immunol. 2020;11:583934.","DOI":"10.3389\/fimmu.2020.583934"},{"key":"3711_CR55","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jinf.2013.03.008","volume":"67","author":"FS Sarfo","year":"2013","unstructured":"Sarfo FS, Keegan R, Appiah L, Shakoor S, Phillips R, Norman B, et al. High prevalence of renal dysfunction and association with risk of death amongst HIV-infected Ghanaians. Journal of Infection. 2013;67:43\u201350.","journal-title":"Journal of Infection."},{"key":"3711_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12882-021-02526-4","volume":"22","author":"V Valdivia-Cerda","year":"2021","unstructured":"Valdivia-Cerda V, Alvarez-Zavala M, S\u00e1nchez-Reyes K, Cabrera-Silva RI, Ruiz-Herrera VV, Loza-Salazar AD, et al. Prevalence and risk factors of chronic kidney disease in an HIV positive Mexican cohort. BMC Nephrol. 2021;22:1\u20137.","journal-title":"BMC Nephrol."},{"key":"3711_CR57","doi-asserted-by":"crossref","unstructured":"Mwemezi O, Ruggajo P, Mngumi J, Furia FF. Renal Dysfunction among HIV-Infected Patients on Antiretroviral Therapy in Dar es Salaam, Tanzania: A Cross-Sectional Study. Int J Nephrol. 2020;2020.","DOI":"10.1155\/2020\/8378947"},{"key":"3711_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4102\/sajhivmed.v19i1.770","volume":"19","author":"S Assaram","year":"2018","unstructured":"Assaram S, Mashamba-Thompson TP, Magula NP. Risk factors and co-morbidities associated with changes in renal function among antiretroviral treatment-na\u00efve adults in South Africa: A chart review. South Afr J HIV Med. 2018;19:1\u201311.","journal-title":"South Afr J HIV Med."},{"key":"3711_CR59","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1177\/2325957413488169","volume":"13","author":"OD Onodugo","year":"2014","unstructured":"Onodugo OD, Chukwuka C, Onyedum C, Ejim E, Mbah A, Nkwo P, et al. Baseline renal function among antiretroviral therapy-naive, HIV-infected patients in southeast Nigeria. J Int Assoc Provid AIDS Care. 2014;13:476\u201380.","journal-title":"J Int Assoc Provid AIDS Care."},{"key":"3711_CR60","first-page":"1","volume":"97","author":"UE Ekrikpo","year":"2018","unstructured":"Ekrikpo UE, Kengne AP, Akpan EE, Effa EE, Bello AK, Ekott JU, et al. Prevalence and correlates of chronic kidney disease (CKD) among ART-naive HIV patients in the Niger-Delta region of Nigeria. Medicine (United States). 2018;97:1\u20136.","journal-title":"Medicine (United States)."},{"key":"3711_CR61","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/nep.12031","volume":"18","author":"Y Cao","year":"2013","unstructured":"Cao Y, Gong M, Han Y, Xie J, Li X, Zhang L, et al. Prevalence and risk factors for chronic kidney disease among HIV-infected antiretroviral therapy-na\u00efve patients in Mainland China: A multicenter cross-sectional study. Nephrology. 2013;18:307\u201312.","journal-title":"Nephrology."},{"key":"3711_CR62","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/j.1468-1293.2007.00500.x","volume":"8","author":"SM Curkendall","year":"2007","unstructured":"Curkendall SM, Richardson JT, Emons MF, Fisher AE, Everhard F. Incidence of anaemia among HIV - Infected patients treated with highly active antiretroviral therapy. HIV Med. 2007;8:483\u201390.","journal-title":"HIV Med."},{"key":"3711_CR63","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez-Montoro JI, Morales E, Cornejo-Pareja I, Tinahones FJ, Fern\u00e1ndez-Garc\u00eda JC. Obesity-related glomerulopathy: Current approaches and future perspectives. Obesity Reviews. 2022;23.","DOI":"10.1111\/obr.13450"},{"key":"3711_CR64","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1016\/j.kint.2016.12.013","volume":"91","author":"C Garofalo","year":"2017","unstructured":"Garofalo C, Borrelli S, Minutolo R, Chiodini P, De Nicola L, Conte G. A systematic review and meta-analysis suggests obesity predicts onset of chronic kidney disease in the general population. Kidney Int. 2017;91:1224\u201335.","journal-title":"Kidney Int."},{"key":"3711_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1590\/1414-431x202010022","volume":"54","author":"KRD Pinto","year":"2021","unstructured":"Pinto KRD, Feckinghaus CM, Hirakata VN. Obesity as a predictive factor for chronic kidney disease in adults: Systematic review and meta-analysis. Brazilian Journal of Medical and Biological Research. 2021;54:1\u201310.","journal-title":"Brazilian Journal of Medical and Biological Research."},{"key":"3711_CR66","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.1093\/ndt\/gfm350","volume":"22","author":"CY Cheung","year":"2007","unstructured":"Cheung CY, Wong KM, Lee MP, Liu YL, Kwok H, Chung R, et al. Prevalence of chronic kidney disease in Chinese HIV-infected patients. Nephrology Dialysis Transplantation. 2007;22:3186\u201390.","journal-title":"Nephrology Dialysis Transplantation."},{"key":"3711_CR67","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1089\/apc.2009.0326","volume":"24","author":"N Crum-Cianflone","year":"2010","unstructured":"Crum-Cianflone N, Ganesan A, Teneza-Mora N, Riddle M, Medina S, Barahona I, et al. Prevalence and factors associated with renal dysfunction among HIV-infected patients. AIDS Patient Care STDS. 2010;24:353\u201360.","journal-title":"AIDS Patient Care STDS."},{"key":"3711_CR68","doi-asserted-by":"crossref","unstructured":"Kalinjuma AV, Hussey H, Mollel GJ, Letang E, Battegay M, Glass TR, et al. Body mass index trends and its impact of under and overweight on outcome among PLHIV on antiretroviral treatment in rural Tanzania: A prospective cohort study. PLoS One. 2023;18(8):e0290445.","DOI":"10.1371\/journal.pone.0290445"},{"key":"3711_CR69","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0093748","volume":"9","author":"P Santiago","year":"2014","unstructured":"Santiago P, Grinsztejn B, Friedman RK, Cunha CB, Coelho LE, Luz PM, et al. Screening for decreased glomerular filtration rate and associated risk factors in a cohort of HIV-infected patients in a middle-income country. PLoS One. 2014;9: e93748.","journal-title":"PLoS One."},{"key":"3711_CR70","doi-asserted-by":"crossref","unstructured":"Achhra AC, Mocroft A, Ross MJ, Ryom L, Lucas GM, Furrer H, et al. Kidney disease in antiretroviral-na\u00efve HIV-positive adults with high CD4 counts: prevalence and predictors of kidney disease at enrolment in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. HIV Med. 2015;16 Suppl 1 0 1:55\u201363.","DOI":"10.1111\/hiv.12234"},{"key":"3711_CR71","doi-asserted-by":"crossref","unstructured":"Hsieh M-HH, Lu P-LL, Kuo M-CC, Lin W-RR, Lin C-YY, Lai C-CC, et al. Prevalence of and associated factors with chronic kidney disease in human immunodeficiency virus-infected patients in Taiwan. J Microbiol, Immunol Infect. 2015;48:256\u201362.","DOI":"10.1016\/j.jmii.2013.08.013"},{"key":"3711_CR72","doi-asserted-by":"publisher","first-page":"176","DOI":"10.55320\/mjz.44.3.285","volume":"44","author":"S Tembo","year":"2017","unstructured":"Tembo S, Chirwa L, Mulenga LB, Mweemba A, Musonda P. The Prevalence of Kidney Dysfunction and Associated Risk Factors among ART-Na\u00efve HIV-1 infected Adults at the University Teaching Hospital in Lusaka. Zambia Med J Zambia. 2017;44:176\u201383.","journal-title":"Zambia. Med J Zambia."},{"key":"3711_CR73","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12882-017-0497-6","volume":"18","author":"BO Yarnoff","year":"2017","unstructured":"Yarnoff BO, Hoerger TJ, Simpson SK, Leib A, Burrows NR, Shrestha SS, et al. The cost-effectiveness of using chronic kidney disease risk scores to screen for early-stage chronic kidney disease. BMC Nephrol. 2017;18:85.","journal-title":"BMC Nephrol."},{"key":"3711_CR74","doi-asserted-by":"crossref","unstructured":"Boyd MA, Mocroft A, Ryom L, Monforte A d\u2019Arminio, Sabin C, El-Sadr WM, et al. Cardiovascular disease (CVD) and chronic kidney disease (CKD) event rates in HIV-positive persons at high predicted CVD and CKD risk: A prospective analysis of the D:A:D observational study. PLoS Med. 2017;14:e1002424.","DOI":"10.1371\/journal.pmed.1002424"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-024-03711-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-024-03711-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-024-03711-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T21:02:38Z","timestamp":1724446958000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-024-03711-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,23]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3711"],"URL":"https:\/\/doi.org\/10.1186\/s12882-024-03711-x","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,23]]},"assertion":[{"value":"11 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval for the study was obtained from the Institutional Review Board (IRB) of the Nigerian Institute of Medical Research (NIMR) \u2013 IRB-21-066 and Health Research Ethics Committee of the University of Cape Town, South Africa \u2013 HREC 176\/2022. Study participants at enrolment into the ART clinic signed informed consent to document their preference concerning the use of their blood samples and data for research during the course of care offered in the clinic. Their responses however did not have any inclination towards the content and quality of care and treatment received in the clinic.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"270"}}